CA:133:332980 Biochem Pharmacol abs Kennedy et al 60(7) pp. 877-883 2000.* |
Biochemistry by Tang et al. 38 pp. 3793-3803 1999.* |
CA:130:267518 by Yokomatsu et al 9(4) pp. 529-532 1999.* |
Pierre L. Beaulieu, et al., J. Med. Chem. 1999, 42, 1757-1766. |
K. Blades, et al., Chem. Commun., 1615-1616, 1996. |
Terrence R. Burke, Jr., et al., Bioorganic & Medicinal Chemistry Letters 9 (1999) 347-352. |
Neil A. Caplan, et al., Bioorganic & Medicinal Chemistry Letters 8 (1998) 515-520. |
Paul S. Charifson, et al., Biochemistry 1997, 36, 6283-6293. |
G. Stuart Cockerill, et al., Tetrahedron Letters 40 (1999) 2601-2604. |
G. Stuart Cockerill, et al., J. Chem. Soc., Perkin Trans. 1, 2000, 2591-2599. |
Sylvie Desmarais, et al., Biochem. J. (1999) 337, 219-223. |
Mikhail F. Gordeev, et al., Tetrahedron Letters, vol. 35, No. 41, pp. 7585-7588, 1994. |
Hong, J. Enzyme Inhib., vol. 12, pp. 191-203, 1997. |
Christopher c. Kotoris, Bioorganic & Medicinal Chemistry Letters 8 (1998) 3275-3280. |
Christopher C. Kotoris, J. Org. Chem. 1998, 63, 8052-8057. |
Meng Taing, et al., Biochemistry 1999, 38 3793-3803. |
Scott D. Taylor, et al., Bioorganic & Medicinal Chemistry 6 (1998) 1457-1468. |
Scott D. Taylor, et al., Bioorganic & Medicinal Chemistry 6 (1998) 2235. |
Scott D. Taylor, et al., Tetrahedron Letters, vol. 37, No. 45, pp. 8089-8092, 1996. |
Scott D. Taylor, et al., Tetrahedron 54 (1998) 1691-1714. |
Quigping Wang, et al., Bioorganic & Medicinal Chemistry Letters 8 (1998) 345-350. |
Zhu-Jun Yao, et al., Tetrahedron 55 (1999) 2865-2874. |
Bin Ye, et al., Tetrahedron, vol. 52. No. 30., pp. 9963-9970, 1996. |
Tsutomu Yokomatsu, et al., Tetrahedron 54 (1998) 9341-9356. |
Tsutomu Yokomatsu, et al., Bioorganic & Medicinal Chemistry Letters 9 (1999) 529-532. |